title: Use of OKT3 for late acute rejection in liver transplantation.
authors.affiliation: Unité de Chirurgie Hépato-Billaire, Villejuif, France.
authors.forename: D
authors.initials: D
authors.lastname: Samuel
authors.forename: J
authors.initials: J
authors.lastname: Gugenheim
authors.forename: C
authors.initials: C
authors.lastname: Canon
authors.forename: F
authors.initials: F
authors.lastname: Saliba
authors.forename: H
authors.initials: H
authors.lastname: Bismuth
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D001663:Bilirubin / Q000097:blood; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection; D006801:Humans; D007165:Immunosuppression Therapy; D008107:Liver Diseases / Q000601:surgery; D008111:Liver Function Tests; D016031:Liver Transplantation / Q000276:immunology* / Q000502:physiology; D008297:Male; D016853:Muromonab-CD3
chemical_list: D000911:Antibodies, Monoclonal; D016853:Muromonab-CD3; D001663:Bilirubin